The recent instability in global chains have highlighted the importance of securing vital medications like Ivermectin. Trusting on overseas manufacturers exposes countries to considerable vulnerabilities, including delivery delays, cost fluctuations, and even political threats. Transitioning towards domestic sourcing of Ivermectin offers a multitud